Compare IMA & FRMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMA | FRMM |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | 17 | 2 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 65.8M |
| IPO Year | N/A | 2017 |
| Metric | IMA | FRMM |
|---|---|---|
| Price | $5.95 | $5.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.00 | $5.00 |
| AVG Volume (30 Days) | 14.5K | ★ 292.6K |
| Earning Date | 05-15-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $183.55 |
| Revenue Next Year | N/A | $166.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.94 | $1.76 |
| 52 Week High | $17.50 | $5.87 |
| Indicator | IMA | FRMM |
|---|---|---|
| Relative Strength Index (RSI) | 57.46 | 54.09 |
| Support Level | $5.70 | $3.61 |
| Resistance Level | $6.06 | $5.37 |
| Average True Range (ATR) | 0.29 | 0.43 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 77.03 | 41.58 |
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.